Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine in Esophageal Manometry
NCT03967197Phase 3Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in procedural pain (2 arms), sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Presence of pain during catheter insertion. Started Aug 2019; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT03967197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03967197.